Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trial
Titel:
Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trial
Auteur:
Tweed, Conor D Dawson, Rodney Burger, Divan A Conradie, Almari Crook, Angela M Mendel, Carl M Conradie, Francesca Diacon, Andreas H Ntinginya, Nyanda E Everitt, Daniel E Haraka, Frederick Li, Mengchun van Niekerk, Christo H Okwera, Alphonse Rassool, Mohammed S Reither, Klaus Sebe, Modulakgotla A Staples, Suzanne Variava, Ebrahim Spigelman, Melvin
Verschenen in:
Lancet respiratory medicine
Paginering:
Jaargang 7 () nr. 12 pagina's 1048-1058
Jaar:
2019
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license